FASEB BioAdvances
John Wiley and Sons Inc
United Kingdom
journal
SJR by Edition
Subject Categories
- Biochemistry, Genetics and Molecular Biology (miscellaneous)Q2
- Molecular MedicineQ2
- PhysiologyQ2
- Cancer ResearchQ3
Areas: Biochemistry, Genetics and Molecular Biology
Most published research topics
Source: OpenAlex
Publication Statistics
Documents per Year
Detailed Information
ISSN
2573-9832
SJR Best Quartile
Q2
Region
Western Europe
Citations per Document (2 years)
2.31
References per Document
61.68
Coverage
2019-2026
Scope
FASEB BioAdvances is an international open-access journal of the Federation of American Societies for Experimental Biology (FASEB). FASEB is the nation’s largest federation of U.S. biomedical societies, representing more than 115,000 researchers worldwide and is dedicated to advancing the biological and biomedical sciences. FASEB BioAdvances welcomes submissions reporting original research across the wide realm of the life sciences, across scales of complexity—from molecules, cells and organs to whole organisms, populations and ecosystems, as well as interdisciplinary biological and biomedical research interfacing with other disciplines. In addition to original research, the journal publishes methods and other novel tools/approaches of interest, negative findings that address important unresolved issues, expert reviews, and perspectives on the broader issues affecting academia, science and society. The journal invites submissions from authors around the globe and commits to providing a fair and robust peer review process, rapid handling, and the broadest dissemination of content.
Metrics from SCImago Journal Rank 2025. View on SCImago